Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Rifampin-Resistant Tuberculosis In The United States, 1998-2014.

Sharling L, Marks SM, Goodman M, Chorba T, Mase S.

Clin Infect Dis. 2019 Jun 22. pii: ciz491. doi: 10.1093/cid/ciz491. [Epub ahead of print]

PMID:
31233131
2.

The Impact of a Fogarty International Center-Supported Tuberculosis Research Training Program in the Country of Georgia.

Kempker RR, Tukvadze N, Sthreshley L, Sharling L, Comeau DL, Magee MJ, Del Rio C, Avaliani Z, Blumberg HM.

Am J Trop Med Hyg. 2018 Apr;98(4):1069-1074. doi: 10.4269/ajtmh.17-0667. Epub 2018 Feb 1.

3.

Knowledge, attitudes, and practices regarding cervical cancer and screening among Ethiopian health care workers.

Kress CM, Sharling L, Owen-Smith AA, Desalegn D, Blumberg HM, Goedken J.

Int J Womens Health. 2015 Jul 31;7:765-72. doi: 10.2147/IJWH.S85138. eCollection 2015.

4.

Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.

Gorla SK, Kavitha M, Zhang M, Liu X, Sharling L, Gollapalli DR, Striepen B, Hedstrom L, Cuny GD.

J Med Chem. 2012 Sep 13;55(17):7759-71. doi: 10.1021/jm3007917. Epub 2012 Sep 5.

5.

Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.

Kirubakaran S, Gorla SK, Sharling L, Zhang M, Liu X, Ray SS, Macpherson IS, Striepen B, Hedstrom L, Cuny GD.

Bioorg Med Chem Lett. 2012 Mar 1;22(5):1985-8. doi: 10.1016/j.bmcl.2012.01.029. Epub 2012 Jan 24.

6.

A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.

Sharling L, Liu X, Gollapalli DR, Maurya SK, Hedstrom L, Striepen B.

PLoS Negl Trop Dis. 2010 Aug 10;4(8):e794. doi: 10.1371/journal.pntd.0000794.

7.

Prodrug activation by Cryptosporidium thymidine kinase.

Sun XE, Sharling L, Muthalagi M, Mudeppa DG, Pankiewicz KW, Felczak K, Rathod PK, Mead J, Striepen B, Hedstrom L.

J Biol Chem. 2010 May 21;285(21):15916-22. doi: 10.1074/jbc.M110.101543. Epub 2010 Mar 15.

8.

Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.

Umejiego NN, Gollapalli D, Sharling L, Volftsun A, Lu J, Benjamin NN, Stroupe AH, Riera TV, Striepen B, Hedstrom L.

Chem Biol. 2008 Jan;15(1):70-7. doi: 10.1016/j.chembiol.2007.12.010. Erratum in: Chem Biol. 2008 Feb;15(2):200.

9.
10.

Plasmodium cysteine repeat modular proteins 1-4: complex proteins with roles throughout the malaria parasite life cycle.

Thompson J, Fernandez-Reyes D, Sharling L, Moore SG, Eling WM, Kyes SA, Newbold CI, Kafatos FC, Janse CJ, Waters AP.

Cell Microbiol. 2007 Jun;9(6):1466-80. Epub 2007 Jan 23.

PMID:
17253978
12.

High throughput immuno-screening of cDNA expression libraries produced by in vitro recombination; exploring the Plasmodium falciparum proteome.

Sowa MP, Sharling L, Humphreys G, Cavanagh DR, Gregory WF, Fenn K, Creasey AM, Arnot DE.

Mol Biochem Parasitol. 2004 Feb;133(2):267-74.

PMID:
14698438
13.

Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox.

Edens WA, Sharling L, Cheng G, Shapira R, Kinkade JM, Lee T, Edens HA, Tang X, Sullards C, Flaherty DB, Benian GM, Lambeth JD.

J Cell Biol. 2001 Aug 20;154(4):879-91.

14.

Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex.

Roopra A, Sharling L, Wood IC, Briggs T, Bachfischer U, Paquette AJ, Buckley NJ.

Mol Cell Biol. 2000 Mar;20(6):2147-57.

15.

Repression and activation of muscarinic receptor genes.

Buckley NJ, Bachfischer U, Canut M, Mistry M, Pepitoni S, Roopra A, Sharling L, Wood IC.

Life Sci. 1999;64(6-7):495-9. Review.

PMID:
10069515

Supplemental Content

Loading ...
Support Center